Term
|
Definition
Developed in the 1970's by German pharmaceutical firms Bayer and Merck.
For Schistosomiasis and most flukes.
It is a synthetic Isoquinolone-pyrazine derivative. |
|
|
Term
|
Definition
| Developed by Dr. William Campbell of Merck; first benzimidazole to be developed and licensed for human use. |
|
|
Term
|
Definition
| Introduction of organophosphate antihelminthics |
|
|
Term
|
Definition
| An organophosphate antihelminthic that was eventually removed from the U.S market due to toxicity issues. |
|
|
Term
|
Definition
| Modern age of deworming began. Administered to sheep as a drench and/or included in salt mixtures. Sometimes combined with lead arsenate to control tapeworms. |
|
|
Term
|
Definition
Filiariasis, Loaiasis, Tropical eosinophilia.
Immobilizes microfilariae and alters their surface structe making them more susceptible to destruction by host defense mechanism. |
|
|
Term
|
Definition
Strongyloides and Onchocerciasis.
Alternative drug for scabies. |
|
|
Term
|
Definition
|
|
Term
|
Definition
Used if the patient is allergic to Albendazole and Mebendazole.
Broad Sprectum.
Excreted in the unchanged form (no metabolism) |
|
|
Term
|
Definition
| Hepatotoxic 2-Substituted benzimidazole. |
|
|
Term
|
Definition
Obsolete Drug.
Contraindicated in neurological disorder patients (epilepsy, parkinson's disease) |
|
|
Term
|
Definition
Broad spectrum anti-helminthic drug.
Chemistry: Benzimidazolecarbamate. |
|
|
Term
|
Definition
Tapeworm.
Salicylamide derivative. |
|
|
